Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Urology|November 27, 2019
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: InterpretationBas Israël, Marloes van der Leest, Michiel Sedelaar, et al.
Clinical Nuclear Medicine|August 29, 2018
68Ga-PSMA Uptake in AngiolipomaIrma Dekker, Marloes van der Leest, Maartje C van Rijk, et al.
European Urology|January 9, 2017
Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naïve Men?Martijn G Schouten, Marloes van der Leest, Morgan Pokorny, et al.
European Radiology|January 19, 2024
Diagnostic performance of 3D automated breast ultrasound (3D-ABUS) in a clinical screening setting-a retrospective studyFemke Klein Wolterink, Nazimah Ab Mumin, Linda Appelman, et al.
World Journal of Urology|September 6, 2017
Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancerWulphert Venderink, Marloes van der Leest, Annemarijke van Luijtelaar, et al.
BMJ Open|August 17, 2025
Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study)Sebastiaan W van Koeverden, Lisa Mc van Hoogstraten, Maarten de Rooij, et al.
European Urology Oncology|September 15, 2019
Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled TrialOlivier Wegelin, Leonie Exterkate, Marloes van der Leest, et al.
European Urology|March 5, 2017
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate CancerWulphert Venderink, Annemarijke van Luijtelaar, Joyce G R Bomers, et al.
BJU International|August 6, 2021
Clinical implementation of pre-biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancerBas Israël, Jos Immerzeel, Marloes van der Leest, et al.
BJU International|June 26, 2019
Multiparametric magnetic resonance imaging and follow-up to avoid prostate biopsy in 4259 menWulphert Venderink, Annemarijke van Luijtelaar, Marloes van der Leest, et al.
Pageof 2